Genome-wide expression profiling of a cardiac pressure overload model identifies major metabolic and signaling pathway responses

Journal of Molecular and Cellular Cardiology

Volumn 37, Issue 6, 2004, Pages 1159-1170

  Wagner, Roger A ^a   Tabibiazar, Raymond ^a   Powers, Jennifer ^b   Bernstein, Daniel ^b   Quertermous, Thomas ^a  

^a STANFORD UNIVERSITY   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cell signaling; Energy metabolism; Heart failure; Hypertrophy; Pressure overload; Transcriptional profiling

Indexed keywords

G PROTEIN COUPLED RECEPTOR;

ANGIOGENESIS; ANIMAL MODEL; ANIMAL TISSUE; AORTA CONSTRICTION; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOSKELETON; ENERGY; FATTY ACID OXIDATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEART ATRIUM ENLARGEMENT; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE METABOLISM; HEART VENTRICLE OVERLOAD; HEART VENTRICLE PRESSURE; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE PHOSPHORYLATION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STATISTICAL ANALYSIS;

MAMMALIA;

EID: 9644290762     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2004.09.003     Document Type: Article

References (63)

1. E. Braunwald Shattuck lecture--cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities N. Engl. J. Med. 337 1997 1360 1369
2. E. Lonn, J. Mathew, J. Pogue, D. Johnstone, K. Danisa, and J. Bosch Relationship of electrocardiographic left ventricular hypertrophy to mortality and cardiovascular morbidity in high-risk patients J. Cardiovasc. Risk 10 2003 420 428
3. J. Mathew, P. Sleight, E. Lonn, D. Johnstone, J. Pogue, and Q. Yi Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril Circulation 104 2001 1615 1621
4. D.M. Hwang, A.A. Dempsey, C.Y. Lee, and C.C. Liew Identification of differentially expressed genes in cardiac hypertrophy by analysis of expressed sequence tags Genomics 66 2000 1 14
5. E.O. Weinberg, M. Mirotsou, J. Gannon, V.J. Dzau, R.T. Lee, and R.E. Pratt Sex dependence and temporal dependence of the left ventricular genomic response to pressure overload Physiol. Genomics 12 2003 113 127
6. R.L. Nicol, N. Frey, and E.N. Olson From the sarcomere to the nucleus: role of genetics and signaling in structural heart disease Annu. Rev. Genomics Hum. Genet. 1 2000 179 223
7. R. Passier, H. Zeng, N. Frey, F.J. Naya, R.L. Nicol, and T.A. McKinsey CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo J. Clin. Invest. 105 2000 1395 1406
8. C.L. Antos, T.A. McKinsey, N. Frey, W. Kutschke, J. McAnally, and J.M. Shelton Activated glycogen synthase-3 beta suppresses cardiac hypertrophy in vivo Proc. Natl. Acad. Sci. USA 99 2002 907 912
9. N. Frey, and E.N. Olson Cardiac hypertrophy: the good, the bad, and the ugly Annu.Rev. Physiol. 65 2003 45 79
10. C.J. Friddle, T. Koga, E.M. Rubin, and J. Bristow Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy Proc. Natl. Acad. Sci. USA 97 2000 6745 6750
11. B. Swynghedauw, and C. Baillard Biology of hypertensive cardiopathy Curr. Opin. Cardiol. 15 2000 247 253
12. M. Mirotsou, C.M. Watanabe, P.G. Schultz, R.E. Pratt, and V.J. Dzau Elucidating the molecular mechanism of cardiac remodeling using a comparative genomic approach Physiol. Genomics 15 2003 115 126
13. S. Ghatpande, S. Goswami, E. Mascareno, and M.A. Siddiqui Signal transduction and transcriptional adaptation in embryonic heart development and during myocardial hypertrophy Mol. Cell. Biochem. 196 1999 93 97
14. C. Depre, P.J. Davies, and H. Taegtmeyer Transcriptional adaptation of the heart to mechanical unloading Am. J. Cardiol. 83 1999 58H 63H
15. C. Depre, G.L. Shipley, W. Chen, Q. Han, T. Doenst, and M.L. Moore Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy Nat. Med. 4 1998 1269 1275
16. P.M. Barger, J.M. Brandt, T.C. Leone, C.J. Weinheimer, and D.P. Kelly Deactivation of peroxisome proliferator-activated receptor-alpha during cardiac hypertrophic growth J. Clin. Invest. 105 2000 1723 1730
17. P.M. Barger, and D.P. Kelly PPAR signaling in the control of cardiac energy metabolism Trends Cardiovasc. Med. 10 2000 238 245
18. P.M. Barger, A.C. Browning, A.N. Garner, and D.P. Kelly p38 mitogen-activated protein kinase activates peroxisome proliferator-activated receptor alpha: a potential role in the cardiac metabolic stress response J. Biol. Chem. 276 2001 44495 44501
19. J. Marin-Garcia, M.J. Goldenthal, and G.W. Moe Mitochondrial pathology in cardiac failure Cardiovasc.Res. 49 2001 17 26
20. H. Ashrafian, C. Redwood, E. Blair, and H. Watkins Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion Trends Genet 19 2003 263 268
21. R.F. Ventura-Clapier, A. Garnier, and V. Veksler Energy metabolism in heart failure J. Physiol. 555 2003 1 13
22. A. Nakamura, D.G. Rokosh, M. Paccanaro, R.R. Yee, P.C. Simpson, and W. Grossman LV systolic performance improves with development of hypertrophy after transverse aortic constriction in mice Am. J. Physiol. Heart. Circ. Physiol. 281 2001 H1104 H1112
23. H.A. Rockman, R.S. Ross, A.N. Harris, K.U. Knowlton, M.E. Steinhelper, and L.J. Field Segregation of atrial-specific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy Proc. Natl. Acad. Sci. USA 88 1991 8277 8281
24. G.A. Churchill Fundamentals of experimental design for cDNA microarrays Nat Genet 32 Suppl 2002 490 495
25. C.M. Kendziorski, Y. Zhang, H. Lan, and A.D. Attie The efficiency of pooling mRNA in microarray experiments Biostatistics 4 2003 465 477
26. X. Peng, C.L. Wood, E.M. Blalock, K.C. Chen, P.W. Landfield, and A.J. Stromberg Statistical implications of pooling RNA samples for microarray experiments BMC Bioinformatics 4 2003 26
27. D. Agrawal, T. Chen, R. Irby, J. Quackenbush, A.F. Chambers, and M. Szabo Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling J. Natl. Cancer Inst. 94 2002 513 521
28. R. Tabibiazar, R.A. Wagner, A. Liao, and T. Quertermous Transcriptional profiling of the heart reveals chamber-specific gene expression patterns Circ Res 93 2003 1193 1201
29. V.G. Tusher, R. Tibshirani, and G. Chu Significance analysis of microarrays applied to the ionizing radiation response Proc. Natl. Acad. Sci. USA 98 2001 5116 5121
30. M.M. Chen, E.A. Ashley, D.X. Deng, A. Tsalenko, A. Deng, and R. Tabibiazar Novel role for the potent endogenous inotrope apelin in human cardiac dysfunction Circulation 108 2003 1432 1439
31. B.R. Zeeberg, W. Feng, G. Wang, M.D. Wang, A.T. Fojo, and M. Sunshine GoMiner: a resource for biological interpretation of genomic and proteomic data Genome Biol. 4 2003 R28
32. D.A. Hosack, G. Dennis Jr., B.T. Sherman, H.C. Lane, and R.A. Lempicki Identifying biological themes within lists of genes with EASE Genome Biol. 4 2003 R70
33. R. Tabibiazar, R.A. Wagner, A. Liao, and T. Quertermous Transcriptional profiling of the heart reveals chamber-specific gene expression patterns Circ Res 93 2003 1193 1201
34. M. Azhar, J. Schultz Jel, I. Grupp, G.W. Dorn 2nd, P. Meneton, and D.G. Molin Transforming growth factor beta in cardiovascular development and function Cytokine Growth Factor Rev. 14 2003 391 407
35. D.Y. Li, L.K. Sorensen, B.S. Brooke, L.D. Urness, E.C. Davis, and D.G. Taylor Defective angiogenesis in mice lacking endoglin Science 284 1999 1534 1537
36. T. Wieland, and C. Mittmann Regulators of G-protein signalling: multifunctional proteins with impact on signalling in the cardiovascular system Pharmacol Ther. 97 2003 95 115
37. S.P. Heximer, R.H. Knutsen, X. Sun, K.M. Kaltenbronn, M.H. Rhee, and N. Peng Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice J. Clin. Invest 111 2003 445 452
38. M. Tang, G. Wang, P. Lu, R.H. Karas, M. Aronovitz, and S.P. Heximer Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure Nat. Med. 9 2003 1506 1512
39. V.P. Sah, S. Minamisawa, S.P. Tam, T.H. Wu, G.W. Dorn 2nd, and J. Ross Jr. Cardiac-specific overexpression of RhoA results in sinus and atrioventricular nodal dysfunction and contractile failure J. Clin. Invest. 103 1999 1627 1634
40. L. Wei, K. Imanaka-Yoshida, L. Wang, S. Zhan, M.D. Schneider, and F.J. DeMayo Inhibition of Rho family GTPases by Rho GDP dissociation inhibitor disrupts cardiac morphogenesis and inhibits cardiomyocyte proliferation Development 129 2002 1705 1714
41. P. Staller, J. Sulitkova, J. Lisztwan, H. Moch, E.J. Oakeley, and W. Krek Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL Nature 425 2003 307 311
42. R.J. O'Brien, I. Loke, J.E. Davies, I.B. Squire, and L.L. Ng Myotrophin in human heart failure J. Am. Coll. Cardiol. 42 2003 719 725
43. M. Jessup, and S. Brozena Heart failure New Engl. J. Med. 348 2003 2007 2018
44. K.T. Weber Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation Circulation 96 1997 4065 4082
45. I. Medugorac Collagen content in different areas of normal and hypertrophied rat myocardium Cardiovasc. Res. 14 1980 551 554
46. T. Onoda, T. Ono, D.K. Dhar, A. Yamanoi, T. Fujii, and N. Nagasue Doxycycline inhibits cell proliferation and invasive potential: combination therapy with cyclooxygenase-2 inhibitor in human colorectal cancer cells J. Lab. Clin. Med. 143 2004 207 216
47. N.A. Rizvi, J.S. Humphrey, E.A. Ness, M.D. Johnson, E. Gupta, and K. Williams A phase I study of oral BMS-275291, a novel nonhydroxamate sheddase-sparing matrix metalloproteinase inhibitor, in patients with advanced or metastatic cancer Clin. Cancer Res. 10 2004 1963 1970
48. M. Demestre, G.M. Wells, K.M. Miller, K.J. Smith, R.A. Hughes, and A.J. Gearing Characterisation of matrix metalloproteinases and the effects of a broad-spectrum inhibitor (BB-1101) in peripheral nerve regeneration Neuroscience 124 2004 767 779
49. P.K. Busk, J. Bartkova, C.C. Strom, L. Wulf-Andersen, R. Hinrichsen, and T.E. Christoffersen Involvement of cyclin D activity in left ventricle hypertrophy in vivo and in vitro Cardiovasc Res 56 2002 64 75
50. R.A. Poolman, and G. Brooks Expressions and activities of cell cycle regulatory molecules during the transition from myocyte hyperplasia to hypertrophy J. Mol. Cell. Cardiol. 30 1998 2121 2135
51. M. Tamamori, H. Ito, M. Hiroe, Y. Terada, F. Marumo, and M.A. Ikeda Essential roles for G1 cyclin-dependent kinase activity in development of cardiomyocyte hypertrophy Am. J. Physiol. 275 1998 H2036 H2040
52. D. Vara, K.A. Bicknell, C.H. Coxon, and G. Brooks Inhibition of E2F abrogates the development of cardiac myocyte hypertrophy J. Biol. Chem. 278 2003 21388 21394
53. Y. Nakajima, T. Yamagishi, K. Ando, and H. Nakamura Significance of bone morphogenetic protein-4 function in the initial myofibrillogenesis of chick cardiogenesis Dev. Biol. 245 2002 291 303
54. M.J. Walters, G.A. Wayman, and J.L. Christian Bone morphogenetic protein function is required for terminal differentiation of the heart but not for early expression of cardiac marker genes Mech. Dev. 100 2001 263 273
55. R.W. Stottmann, M. Choi, Y. Mishina, E.N. Meyers, and J. Klingensmith BMP receptor IA is required in mammalian neural crest cells for development of the cardiac outflow tract and ventricular myocardium Development 131 2004 2205 2218
56. V. Gaussin, T. Van de Putte, Y. Mishina, M.C. Hanks, A. Zwijsen, and D. Huylebroeck Endocardial cushion and myocardial defects after cardiac myocyte-specific conditional deletion of the bone morphogenetic protein receptor ALK3 Proc. Natl. Acad. Sci. USA 99 2002 2878 2883
57. K. Brusselmans, V. Compernolle, M. Tjwa, M.S. Wiesener, P.H. Maxwell, and D. Collen Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia J. Clin. Invest. 111 2003 1519 1527
58. R.A. De Boer, Y.M. Pinto, and D.J. Van Veldhuisen The imbalance between oxygen demand and supply as a potential mechanism in the pathophysiology of heart failure: the role of microvascular growth and abnormalities Microcirculation 10 2003 113 126
59. I. Friehs, A.M. Moran, C. Stamm, Y.H. Choi, D.B. Cowan, and F.X. McGowan Promoting angiogenesis protects severely hypertrophied hearts from ischemic injury Ann. Thorac. Surg. 77 2004 2004 2010 [discussion 2011]
60. J.J. Lehman, and D.P. Kelly Gene regulatory mechanisms governing energy metabolism during cardiac hypertrophic growth Heart Fail. Rev. 7 2002 175 185
61. J.J. Lehman, and D.P. Kelly Transcriptional activation of energy metabolic switches in the developing and hypertrophied heart Clin. Exp. Pharmacol. Physiol. 29 2002 339 345
62. G. Kessler, and J. Friedman Metabolism of fatty acids and glucose Circulation 98 1998 1351
63. M. Van Bilsen, P.J. Smeets, A.J. Gilde, and G.J. Van der Vusse Metabolic remodelling of the failing heart: the cardiac burn-out syndrome? Cardiovasc. Res. 61 2004 218 226